Eyenovia, Inc.
(NASDAQ : EYEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.00%141.860.7%$1091.40m
PFEPfizer Inc.
0.39%43.670.9%$889.76m
MRKMerck & Co., Inc.
-1.15%84.380.6%$745.59m
BMYBristol-Myers Squibb Company
0.58%48.891.4%$531.93m
LLYEli Lilly and Company
0.29%115.571.0%$485.15m
ABBVAbbVie, Inc.
1.33%78.642.2%$356.51m
NVSNovartis AG Sponsored ADR
0.54%92.400.2%$199.01m
AZNAstraZeneca PLC Sponsored ADR
0.23%41.781.2%$117.67m
GSKGlaxoSmithKline plc Sponsored ADR
-0.81%40.670.2%$89.26m
SNYSanofi Sponsored ADR
-0.18%44.000.2%$87.00m
NVONovo Nordisk A/S Sponsored ADR Class B
-2.60%51.060.1%$76.94m
LCILannett Company, Inc.
0.26%5.7036.6%$4.61m
AKTXAkari Therapeutics Plc Sponsored ADR
-5.94%2.061.6%$0.42m
EPIXESSA Pharma Inc
3.27%2.380.1%$0.01m

Company Profile

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The company was founded on March 12, 2014 and is headquartered in New York, NY.